- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02777112
The Effects of E-mental Health Program and Job Coaching on the Risk of Major Depression in Canadian Working Men
The Effects of E-mental Health Program and Job Coaching on the Risk of Major Depression and Productivity in Canadian Male Workers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Objective:
Among Canadian male workers who are at high risk of having major depressive episode (MDE), to evaluate the impacts of an e-mental health intervention and telephone-based job coaching on the 12-month risk proportion of MDE. MDE will be measured by the WHO's CIDI-SFMD.
Hypothesis: The risk proportions of MDE in the intervention groups will be lower than that in the control group over 12 months.
Secondary Objectives:
Among Canadian male workers who are at high risk of having MDE,
to evaluate the impacts of an e-mental health intervention and telephone-based job coaching on:
- Changes in depression score
- Changes in anxiety score
- Changes in absenteeism
- Changes in presenteeism
- Return on investment
- Predicted MDE risk
Depression and anxiety scores will be measured by the Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder (GAD-7), respectively. Absenteeism and presenteeism will be measured by the WHO's Health and Work Performance Questionnaire (HPQ).
Hypothesis I: The reductions in depressive and anxiety scores in the intervention groups will be greater than those in the control group over 12 months.
Hypothesis II: The means of negative changes in absenteeism and presenteeism scores in the intervention groups will be lower than those in the control group.
Hypothesis III: Participants in the intervention groups will have greater reduction in predicted MDE risk than those in the control group.
To compare participants who receive e-mental health program only and those who receive e-mental health program and job coaching services in
- One-year proportion of MDE
- Changes in depression score
- Changes in anxiety score
- Changes in absenteeism
- Changes in presenteeism
- Return on investment
- Predicted MDE risk
Hypothesis IV: The risk proportion of MDE in the e-mental health plus job coaching group will be lower than that in the e-mental health only group.
Hypothesis V: The reduction in depression and anxiety scores in the e-mental health plus job coaching group will be greater than those in the e-mental health program only group.
Hypothesis VI: The means of negative changes in absenteeism and presenteeism scores in the e-mental health plus job coaching group will be lower than those in the e-mental health program only group.
Hypothesis VII: Participants in the e-mental health plus job coaching group will have greater reduction in predicted MDE risk than those in the e-mental health program only group.
The proposed mixed-methods study is a prospective, intention-to-treat, randomized controlled trial with 3 arms:
- Control group (n = 400): individuals will receive general information about men's mental health
- Intervention arm 1 (n = 400): individuals will receive the e-mental health program.
- Intervention arm 2 (n = 400): individuals will receive the e-mental health program, and telephone based interactive work-life coaching.
An embedded qualitative interview component will be conducted with a sub sample of participants from the intervention groups to obtain in-depth perspectives about the effectiveness of interventions at the 12-month.
Recruitment and Screening will be contracted to a telephone interview firm that has access to the numbers of household landlines and cell phones across the country. Recruitment will be conducted using the method of Random Digit Dialing (RDD).
Online assessment: To ensure the use of the Internet, participants who complete the baseline telephone assessment are instructed to complete an online survey as the last step of the baseline assessment and informed consent. The online survey will include:
- A brief description of the purpose of the trial and commitment of privacy protection
- The Internet use (2 questions)
- The 12-item Job Content Questionnaire used in the Statistics Canada survey to measure self-reported work stress
- Consent and submission.
Randomization. Participants who complete the baseline telephone and online surveys will be randomized into intervention and control groups. The randomization will be conducted and managed by the project coordinator affiliated with the project.
1200 random numbers (between 0 and 1) will first be generated using Excel ("RAND()") for 1200 study identification numbers (ID), ranging from 1 to 1200. The 1200 random numbers will then be sorted at the descending order and categorized into 3 equal groups:
- the ID numbers in the first group (n = 400) will be allocated to the control group
- the ID numbers in the second group (n = 400) will be allocated to the e-mental health program only
- the ID numbers in the third group (n = 400) will be allocated to the e-mental health group plus job coaching.
The Excel sheet with ID numbers and random numbers will be kept and printed out for randomization.
For example, a participant is the 3rd one who completes the online survey, which is determined by the date of completion. The project coordinator will search for ID #3 on the Excel sheet. The ID #3 is in the second group. This participant will be assigned to the group that will receive e-mental health program only.
The date of randomization will be documented. Any outcomes/changes that occur after the randomization will be counted to the groups, regardless of course of the e-mental health and job coaching interventions and if the interventions are used by the participants.
After randomization, the project coordinator will contact the participant by email. For those in the control group, the email will include a link to the men's mental health page of the Movember Foundation website; for those in the e-mental health only group, the email will include a link to the e-mental health program log-in page, and the user name. Password will be send in a separate email; for those in the e-mental health plus job coaching group, the email will include a link to the page for e-mental health program and appointment booking system, and the user name. Password will be send in a separate email.
After randomization, a package including the following materials will be mailed to the participants:
- A thank-you letter
- the Movember Foundation web site link to men's mental health: https://ca.movember.com/mens-health/mental-health
- $20 incentive as appreciation of their participation.
The project coordinator will not be involved in follow-up data collection.
Follow-up assessments: The post-randomization assessments will be conducted at 6 months and 12 months by interviewers at the Mathison Centre for Mental Health & Education, University of Calgary.
To obtain in-depth information about how the e-mental health solution affects men's behaviors and risk profile, qualitative interviews will be conducted via telephone with 10% of participants in the intervention groups at the end of the randomized controlled trial (RCT) (i.e., after the 12-month assessment). The participants will represent those with diverse outcomes (clinical and occupational trajectories, and employment status changes). Qualitative interview data will yield in-depth data about the impacts of receiving the e-mental health solution and depression risk information on the outcomes. These data will be used to support and interpret the primary quantitative data base. The multiple forms of evidence generated through mixed methods designs are particularly useful for illuminating complex health issues.36
Data management: The telephone interview firm will transfer password protected baseline data to the PI on a monthly basis. The group assignment data will be transferred in a separate file. The 6- and 12-month follow-up assessments will be conducted at the telephone interview laboratory at the Mathison Centre for Mental Health Research & Education (the Centre), University of Calgary. There are 5 trained telephone interviewers. Of whom, 2 can conduct interviews in English and French. The laboratory has 5 stations which are equipped with the Computer Assisted Telephone Interview provided by the VOXCO company. One month before the scheduled follow-up interviews, letters will be sent to the participants to remind them of the upcoming interview. An interview log will be developed for each participant to document interview time, schedule, call-back, contact information and for the interviewer to make comments.
Over the course of the trial, the principal investigator (PI) and research staff will examine the data on a regular basis by running cross tabulation, frequency distribution and estimation of means and proportions to ensure the quality of the data and identify missing values and potential outliers. If missing values and outliers are found, the records will be referred back to the interviewer for clarification or call-back.
After the 12-month interview, participants' group status will be linked with interview data by study identification (ID) numbers. Over the study period, the investigators and the interviewers who conduct the follow-up interviews in Calgary will not have access to participants' group status. The interviewers who conduct the baseline assessment and randomization, will not be involved in follow-up interviews.
The PI and project coordinator will be responsible for maintaining the data and data quality control. A sub-committee has been formed for this trial. The committee members will communicate via teleconference at bi-monthly basis to review and discuss the progress, operational issues, data analysis and preliminary results.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4Z6
- Mathison Centre for Mental Health Research and Education
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At the time of recruitment, working for pay
- At the time of recruitment and baseline assessment, have a high risk of having major depressive episode (MDE) based on our prediction algorithm. For the proposed study, 6.51+% will be defined as high risk for men
- May have MDE in the past 12 months, but in remission for at least 2 months prior to the study
- Have no language barriers to English or French
- Have access to the internet
- Provide email and mailing address
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Control
This group will receive generic information about depression and serve as control
|
Receiving generic information about men's depression from the Movember Foundation website: https://ca.movember.com/programs/mental-health
Other Names:
|
|
EXPERIMENTAL: e-mental health program
This group will receive the developed e-mental health program
|
This program is delivered over the Internet, which includes modules of Information (about depression, workplace factors and alcohol use), Practical Tips (Cognitive Behavioral Therapy, Mindfulness relaxation, workplace strategies), Tools (for monitoring and predicting depression and occupational functioning), and Goal Setting and Tracking.
|
|
EXPERIMENTAL: e-mental health program and job coaching
This group will receive the developed e-mental health program plus interactive job coaching through telephone.
|
This combines the e-mental health program and interactive job coaching delivered through telephone.
The e-mental health program is delivered over the Internet, which includes modules of Information (about depression, workplace factors and alcohol use), Practical Tips (Cognitive Behavioral Therapy, Mindfulness relaxation, workplace strategies), Tools (for monitoring and predicting depression and occupational functioning), and Goal Setting and Tracking.
The job coaching can be accessed by appointment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk proportion of major depressive episode (MDE) over 12 months
Time Frame: 12-month follow-up assessment
|
MDE occurred over the 12-month follow-up period will be measured by the Composite International Diagnostic Interview
|
12-month follow-up assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in depression score
Time Frame: 6- and 12-month follow-up assessment
|
Depression score will be measured by the Patient Health Questionnaire (PHQ-9)
|
6- and 12-month follow-up assessment
|
|
Change in presenteeism
Time Frame: baseline, 6- and 12-month follow-up assessment
|
To be measured by the World Health Organization (WHO)'s Health and Work Performance Questionnaire
|
baseline, 6- and 12-month follow-up assessment
|
|
Change in absenteeism
Time Frame: baseline, 6- and 12-month follow-up assessment
|
To be measured by the WHO's Health and Work Performance Questionnaire
|
baseline, 6- and 12-month follow-up assessment
|
|
Return on investment
Time Frame: baseline, 6- and 12-month follow-up assessment
|
To be measured by the WHO's Health and Work Performance Questionnaire
|
baseline, 6- and 12-month follow-up assessment
|
|
Change in anxiety score
Time Frame: baseline, 6- and 12-month follow-up assessment
|
Anxiety score will be measured by the Generalized Anxiety Disorder - 7 (GAD-7)
|
baseline, 6- and 12-month follow-up assessment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in sleep disturbance
Time Frame: baseline, 6- and 12-month follow-up assessment
|
To be measured by the scale of the PROMIS
|
baseline, 6- and 12-month follow-up assessment
|
|
Change in anger
Time Frame: baseline, 6- and 12-month follow-up assessment
|
To be measured by the scale of the PROMIS
|
baseline, 6- and 12-month follow-up assessment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: JianLi Wang, University of Calgary
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- #UCAL_01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted